PTHrP-linked Hypercalcemia in a Melanoma Patient Treated with Ipilimumab: Hormone source and Clinical and Metabolic Correlates

A patient diagnosed with metastatic melanoma developed the paraneoplastic syndrome of humoral hypercalcemia of malignancy and cachexia after receiving ipilumumab. The cause of the hypercalcemia was thought to be secondary to parathyroid hormone related peptide (PTHrP) as plasma levels were found to...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Semin Oncol
Autores principales: Mills, Theresa Anne, Orloff, Marlana, Domingo-Vidal, Marina, Cotzia, Paolo, Birbe, Ruth, Draganova-Tacheva, Rossitza, Martinez-Cantarin, Maria Paula, Tuluc, Madalina, Martinez-Outschoorn, Ubaldo
Formato: Artigo
Lenguaje:Inglês
Publicado: 2015
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4663680/
https://ncbi.nlm.nih.gov/pubmed/26615135
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.seminoncol.2015.09.006
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares